Melissa Tosca
Financieel Directeur/CFO bij KIORA PHARMACEUTICALS, INC.
Vermogen: 16 752 $ op 30-04-2024
Profiel
Melissa Tosca is currently working as the EVP-Finance, Chief Financial & Accounting Officer at Kiora Pharmaceuticals, Inc. She also holds the position of Executive Vice President-Finance at the same company.
Previously, she worked at Neomorph, Inc. as the Treasurer & Executive Director-Finance.
Ms. Tosca completed her undergraduate degree at the University of Arizona.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-03-2024 | 34 900 ( 0.13% ) | 16 752 $ | 30-04-2024 |
Actieve functies van Melissa Tosca
| Bedrijven | Functie | Begin |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Financieel Directeur/CFO | - |
Eerdere bekende functies van Melissa Tosca
| Bedrijven | Functie | Einde |
|---|---|---|
Neomorph, Inc.
 Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Neomorph, Inc. is an American venture-backed biotechnology company that focuses on discovering innovative new medicines against 'undruggable' targets to solve critical problems in human health. The company is headquartered in an undisclosed location and has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute. Neomorph's team is comprised of industry-leading experts in protein degradation and molecular glues who are committed to advancing the science and technology of molecular glue drug discovery. The company's patient-first, science-driven approach is complemented by its dedication to a supportive and collaborative work environment. Neomorph was founded by Eric Fischer, Philip Chamberlain, Scott A. Armstrong, and Benjamin Ebert, with Philip Chamberlain serving as the CEO since incorporation. | Financieel Directeur/CFO | - |
Opleiding van Melissa Tosca
| University of Arizona | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Neomorph, Inc.
Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Neomorph, Inc. is an American venture-backed biotechnology company that focuses on discovering innovative new medicines against 'undruggable' targets to solve critical problems in human health. The company is headquartered in an undisclosed location and has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute. Neomorph's team is comprised of industry-leading experts in protein degradation and molecular glues who are committed to advancing the science and technology of molecular glue drug discovery. The company's patient-first, science-driven approach is complemented by its dedication to a supportive and collaborative work environment. Neomorph was founded by Eric Fischer, Philip Chamberlain, Scott A. Armstrong, and Benjamin Ebert, with Philip Chamberlain serving as the CEO since incorporation. | Health Technology |
